Summary of Significant Accounting Policies (Details) - Schedule of antidilutive due to the net loss - shares	12 Months Ended
Dec. 31, 2022	Dec. 31, 2021
Warrants [Member]
Equivalent common shares
Equivalent common shares	18,436	18,436
Unvested Restricted Stock Awards [Member]
Equivalent common shares
Equivalent common shares	237	6,196
Stock options [Member]
Equivalent common shares
Equivalent common shares	1,172,281	669,067

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration